Back to Search
Start Over
Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study
- Source :
- Liver Transplantation, Liver Transplantation, Wiley, 2011, 17 (7), pp.855-65. ⟨10.1002/lt.22299⟩, Liver Transplantation, Wiley, 2011, 17 (7), pp.855-65. 〈10.1002/lt.22299〉
- Publication Year :
- 2011
- Publisher :
- HAL CCSD, 2011.
-
Abstract
- International audience; Liver transplantation (LT) is currently contraindicated in patients with residual or metastatic alveolar echinococcosis (AE) lesions. We evaluated the long-term course of such patients who underwent LT and were subsequently treated with benzimidazoles. Clinical, imaging, serological, and therapeutic data were collected from 5 patients with residual/recurrent AE lesions who survived for more than 15 years. Since 2004, [(18) F]-2-fluoro-2-deoxyglucose (FDG)-positron emission tomography (PET) images were available, and the levels of serum antibodies (Abs) against Echinococcus multilocularis-recombinant antigens were evaluated. Median survival time after LT was 21 years. These patients were from a prospective cohort of 23 patients with AE who underwent LT: 5 of 8 patients with residual/recurrent AE and 4 of 9 patients without residual/recurrent AE were alive in September 2009. High doses of immunosuppressive drugs, the late introduction of therapy with benzimidazoles, its withdrawal due to side effects, and nonadherence to this therapy adversely affected the prognosis. Anti-Em2(plus) and anti-rEm18 Ab levels and standard FDG-PET enabled the efficacy of therapy on the growth of EA lesions to be assessed. However, meaningful variations in Ab levels were observed below diagnostic cutoff values; and in monitoring AE lesions, images of FDG uptake taken 3 hours after its injection were more sensitive than images obtained 1 hour after its injection. In conclusion, benzimidazoles can control residual/recurrent AE lesions after LT. Using anti-rEm18 or anti-Em2(plus) Ab levels and the delayed acquisition of FDG-PET images can improve the functional assessment of disease activity. The potential recurrence of disease, especially in patients with residual or metastatic AE lesions, should not be regarded as a contraindication to LT when AE is considered to be lethal in the short term.
- Subjects :
- Male
MESH : Recurrence
medicine.medical_treatment
Disease
Liver transplantation
Gastroenterology
Serology
0302 clinical medicine
Recurrence
MESH: Fluorodeoxyglucose F18
MESH : Tomography, X-Ray Computed
MESH : Female
Stage (cooking)
Prospective cohort study
[ SDV.MP.MYC ] Life Sciences [q-bio]/Microbiology and Parasitology/Mycology
[SDV.MP.MYC]Life Sciences [q-bio]/Microbiology and Parasitology/Mycology
MESH: Treatment Outcome
0303 health sciences
MESH: Middle Aged
biology
MESH: Echinococcosis, Hepatic
Middle Aged
MESH : Adult
MESH: Positron-Emission Tomography
3. Good health
Treatment Outcome
MESH : Benzimidazoles
MESH: End Stage Liver Disease
030211 gastroenterology & hepatology
Female
MESH: Tomography, X-Ray Computed
MESH: Radiopharmaceuticals
Adult
medicine.medical_specialty
Echinococcosis, Hepatic
MESH: Liver Transplantation
MESH : Male
MESH : Treatment Outcome
End Stage Liver Disease
03 medical and health sciences
Echinococcosis
Fluorodeoxyglucose F18
Internal medicine
medicine
Humans
In patient
MESH : Middle Aged
Contraindication
Transplantation
MESH: Humans
Hepatology
030306 microbiology
business.industry
MESH : Humans
MESH : Positron-Emission Tomography
MESH: Adult
MESH : Fluorodeoxyglucose F18
biology.organism_classification
MESH: Male
Surgery
Liver Transplantation
MESH: Recurrence
Echinococcus
MESH : Radiopharmaceuticals
Positron-Emission Tomography
Benzimidazoles
Radiopharmaceuticals
MESH : Liver Transplantation
business
Tomography, X-Ray Computed
MESH : Echinococcosis, Hepatic
MESH : End Stage Liver Disease
MESH: Benzimidazoles
MESH: Female
Subjects
Details
- Language :
- English
- ISSN :
- 15276465 and 15276473
- Database :
- OpenAIRE
- Journal :
- Liver Transplantation, Liver Transplantation, Wiley, 2011, 17 (7), pp.855-65. ⟨10.1002/lt.22299⟩, Liver Transplantation, Wiley, 2011, 17 (7), pp.855-65. 〈10.1002/lt.22299〉
- Accession number :
- edsair.doi.dedup.....914fc879a61917c86e143a9844d60000
- Full Text :
- https://doi.org/10.1002/lt.22299⟩